Literature DB >> 15302578

Mapping nucleolar and spliceosome localization sequences of neuregulin1-beta3.

Matthew Golding1, Christiana Ruhrberg, Jennifer Sandle, William J Gullick.   

Abstract

Mitogenic growth factors are generally cell surface associated or secreted proteins, which produce effects by binding to cell surface receptor tyrosine kinases. More recently, it has become clear that some of these proteins can accumulate in the nucleus, where they are proposed to have transcriptional activity. We show here that neuregulin1 (NRG1-beta), an EGF-like growth factor, localizes to the cell nuclei of a human breast cancer. We also show that a nonsecreted isoform of this family of ligands, neuregulin1-beta3, localizes to two distinct compartments within the nucleus, nucleoli, and SC35-positive speckles. Importantly, localization of NRG-beta3 to either structure is receptor-independent, as it occurs in cells lacking its cognate receptors, erbB-3 and erbB-4, and is unaffected by removal of the receptor-binding domain. A panel of deletion mutants was used to demonstrate that the first 21 amino acids of the N-terminus are essential for nucleolar localization, while targeting to nuclear speckles requires residues 49-79 of the 241 amino acid protein. These observations support the idea that secretion and subsequent cell surface receptor binding of mitogenic growth factors are not a prerequisite for nuclear localization and that nonsecreted ligands may have highly specific functions in defined nuclear compartments.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15302578     DOI: 10.1016/j.yexcr.2004.05.028

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  10 in total

1.  Neuregulin1 and ErbB expression in the uninjured and regenerating olfactory mucosa.

Authors:  M A Gilbert; B Lin; J Peterson; W Jang; J E Schwob
Journal:  Gene Expr Patterns       Date:  2015-10-19       Impact factor: 1.224

2.  The fibroblast-derived paracrine factor neuregulin-1 has a novel role in regulating the constitutive color and melanocyte function in human skin.

Authors:  Wonseon Choi; Rainer Wolber; Wolfram Gerwat; Tobias Mann; Jan Batzer; Christoph Smuda; Hongfang Liu; Ludger Kolbe; Vincent J Hearing
Journal:  J Cell Sci       Date:  2010-08-24       Impact factor: 5.285

3.  Nuclear moonlighting of the secreted growth factor heregulin drives endocrine-resistant breast cancer independently of HER2/HER3 signaling.

Authors:  Lin Yang; Travis Vander Steen; Ingrid Espinoza; Elisabet Cuyàs; Sara Verdura; Javier A Menendez; Ruth Lupu
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

4.  Effects of schizophrenia risk variation in the NRG1 gene on NRG1-IV splicing during fetal and early postnatal human neocortical development.

Authors:  Clare Paterson; Yanhong Wang; Joel E Kleinman; Amanda J Law
Journal:  Am J Psychiatry       Date:  2014-09       Impact factor: 18.112

Review 5.  The neuregulin family of genes and their multiple splice variants in breast cancer.

Authors:  Nandini V L Hayes; William J Gullick
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-04-15       Impact factor: 2.673

Review 6.  Mechanisms of neuregulin action.

Authors:  David A Talmage
Journal:  Novartis Found Symp       Date:  2008

7.  NRG1 fusions in breast cancer.

Authors:  Karen D Howarth; Tashfina Mirza; Susanna L Cooke; Suet-Feung Chin; Jessica C Pole; Ernest Turro; Matthew D Eldridge; Raquel Manzano Garcia; Oscar M Rueda; Chris Boursnell; Jean E Abraham; Carlos Caldas; Paul A W Edwards
Journal:  Breast Cancer Res       Date:  2021-01-07       Impact factor: 6.466

8.  Transphosphorylation of kinase-dead HER3 and breast cancer progression: a new standpoint or an old concept revisited?

Authors:  Javier A Menendez; Ruth Lupu
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

9.  Heregulin, a new interactor of the telosome/shelterin complex in human telomeres.

Authors:  Javier A Menendez; Louisa Benboudjema; Luciano Vellon; Miguel A Rubio; Ingrid Espinoza; Judith Campisi; Ruth Lupu
Journal:  Oncotarget       Date:  2015-11-24

10.  Neuregulin-1 attenuates experimental cerebral malaria (ECM) pathogenesis by regulating ErbB4/AKT/STAT3 signaling.

Authors:  Mingli Liu; Wesley Solomon; Juan Carlos Cespedes; Nana O Wilson; Byron Ford; Jonathan K Stiles
Journal:  J Neuroinflammation       Date:  2018-04-10       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.